Zeria Pharmaceutical Co., Ltd.
Zeria Pharmaceutical｜Dividend Increase and Shareholder Return Policy 2026 June
Zeria Pharmaceutical Co., Ltd. announced an increase in the year-end dividend for the fiscal year ending March 2026 to 25 yen per share, bringing the total annual dividend to 49 yen. The company emphasizes profits redistribution and maintains a policy of stable dividends.
Key Figures
- Dividend per Share: 25 Yen
- Annual Dividend: 49 Yen
- Total Dividend: 1,102 million Yen
AI要約
Dividend Policy and Details
Zeria Pharmaceutical Co., Ltd. considers shareholder profit return as its top priority, with a basic policy of stable and continuous dividends. The year-end dividend for the fiscal year ending March 2026 is set at 25 yen per share, with a total annual dividend of 49 yen. This represents a 2 yen increase from the previous year's 47 yen. Dividend funds are sourced from retained earnings, and the increase reflects the company's performance and shareholder return preferences.
Future Shareholder Return and Corporate Strategy
Following its fundamental profit distribution policy, Zeria Pharmaceutical Co., Ltd. aims to enhance shareholder value through continued stable dividends. The company will review dividend amounts and shareholder return measures based on performance trends. It emphasizes the importance of profit return to shareholders and strives for long-term corporate value enhancement.
Zeria Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
